466 related articles for article (PubMed ID: 21538786)
41. Incidence and prognosis of vascular complications after transcatheter aortic valve implantation.
Mwipatayi BP; Picardo A; Masilonyane-Jones TV; Larbalestier R; Thomas S; Turner J; Vijayan V; Yong G
J Vasc Surg; 2013 Oct; 58(4):1028-36.e1. PubMed ID: 23993436
[TBL] [Abstract][Full Text] [Related]
42. Permanent pacemaker implantation after transapical transcatheter aortic valve implantation.
D'Ancona G; Pasic M; Unbehaun A; Hetzer R
Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):373-6. PubMed ID: 21788300
[TBL] [Abstract][Full Text] [Related]
43. Conduction disturbances and permanent cardiac pacing after transcatheter implantation of the CoreValve aortic bioprosthesis: initial single centre experience.
Czerwińska K; Hryniewiecki T; Oręziak A; Dąbrowski M; Michałowska I; Witkowski A; Demkow M; Stępińska J; Orłowska Baranowska E; Rużyłło W
Kardiol Pol; 2012; 70(2):121-8. PubMed ID: 22427074
[TBL] [Abstract][Full Text] [Related]
44. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature.
Erkapic D; De Rosa S; Kelava A; Lehmann R; Fichtlscherer S; Hohnloser SH
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):391-7. PubMed ID: 22050112
[TBL] [Abstract][Full Text] [Related]
45. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
[TBL] [Abstract][Full Text] [Related]
46. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
[TBL] [Abstract][Full Text] [Related]
47. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients.
Gurvitch R; Tay EL; Wijesinghe N; Ye J; Nietlispach F; Wood DA; Lichtenstein S; Cheung A; Webb JG
Catheter Cardiovasc Interv; 2011 Dec; 78(7):977-84. PubMed ID: 21656647
[TBL] [Abstract][Full Text] [Related]
48. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
Grube E; Schuler G; Buellesfeld L; Gerckens U; Linke A; Wenaweser P; Sauren B; Mohr FW; Walther T; Zickmann B; Iversen S; Felderhoff T; Cartier R; Bonan R
J Am Coll Cardiol; 2007 Jul; 50(1):69-76. PubMed ID: 17601548
[TBL] [Abstract][Full Text] [Related]
49. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
[TBL] [Abstract][Full Text] [Related]
50. Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation.
Masson JB; Lee M; Boone RH; Al Ali A; Al Bugami S; Hamburger J; John Mancini GB; Ye J; Cheung A; Humphries KH; Wood D; Nietlispach F; Webb JG
Catheter Cardiovasc Interv; 2010 Aug; 76(2):165-73. PubMed ID: 20665855
[TBL] [Abstract][Full Text] [Related]
51. Transcatheter aortic valve implantation for severe aortic stenosis-a new paradigm for multidisciplinary intervention: a prospective cohort study.
Dworakowski R; MacCarthy PA; Monaghan M; Redwood S; El-Gamel A; Young C; Bapat V; Hancock J; Wilson K; Brickham B; Wendler O; Thomas MR
Am Heart J; 2010 Aug; 160(2):237-43. PubMed ID: 20691827
[TBL] [Abstract][Full Text] [Related]
52. Predictors of 6-month poor clinical outcomes after transcatheter aortic valve implantation.
Auffret V; Boulmier D; Oger E; Bedossa M; Donal E; Laurent M; Sost G; Beneux X; Harmouche M; Verhoye JP; Le Breton H
Arch Cardiovasc Dis; 2014 Jan; 107(1):10-20. PubMed ID: 24361056
[TBL] [Abstract][Full Text] [Related]
53. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
54. Transcatheter aortic valve implantation: the new option for high-risk patients with aortic stenosis.
Olasińska-Wiśniewska A; Grygier M; Lesiak M; Trojnarska O; Grajek S
Cardiol J; 2011; 18(4):461-8. PubMed ID: 21769832
[TBL] [Abstract][Full Text] [Related]
55. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries.
Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M
J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786
[TBL] [Abstract][Full Text] [Related]
56. Long-term outcome of elderly patients with severe aortic stenosis as a function of treatment modality.
Pilgrim T; Englberger L; Rothenbühler M; Stortecky S; Ceylan O; O'Sullivan CJ; Huber C; Praz F; Buellesfeld L; Langhammer B; Meier B; Jüni P; Carrel T; Windecker S; Wenaweser P
Heart; 2015 Jan; 101(1):30-6. PubMed ID: 25163691
[TBL] [Abstract][Full Text] [Related]
57. Propensity-matched comparison between Direct Flow Medical, Medtronic Corevalve, and Edwards Sapien XT prostheses: Device success, thirty-day safety, and mortality.
Zhang Y; Pyxaras SA; Wolf A; Schmitz T; Naber CK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1217-25. PubMed ID: 25581785
[TBL] [Abstract][Full Text] [Related]
58. Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis.
Pilgrim T; Kalesan B; Wenaweser P; Huber C; Stortecky S; Buellesfeld L; Khattab AA; Eberle B; Gloekler S; Gsponer T; Meier B; Jüni P; Carrel T; Windecker S
Circ Cardiovasc Interv; 2012 Dec; 5(6):856-61. PubMed ID: 23169986
[TBL] [Abstract][Full Text] [Related]
59. 5-Year Outcomes After Transcatheter Aortic Valve Implantation With CoreValve Prosthesis.
Barbanti M; Petronio AS; Ettori F; Latib A; Bedogni F; De Marco F; Poli A; Boschetti C; De Carlo M; Fiorina C; Colombo A; Brambilla N; Bruschi G; Martina P; Pandolfi C; Giannini C; Curello S; Sgroi C; Gulino S; Patanè M; Ohno Y; Tamburino C; Attizzani GF; Immè S; Gentili A; Tamburino C
JACC Cardiovasc Interv; 2015 Jul; 8(8):1084-1091. PubMed ID: 26117458
[TBL] [Abstract][Full Text] [Related]
60. Clinical presentation and outcomes after transcatheter aortic valve implantation in patients with low flow/low gradient severe aortic stenosis.
Elhmidi Y; Piazza N; Krane M; Deutsch MA; Mazzitelli D; Lange R; Bleiziffer S
Catheter Cardiovasc Interv; 2014 Aug; 84(2):283-90. PubMed ID: 24407885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
